NO20080219L - Fentanylformulering som inneholder en essensiell olje - Google Patents

Fentanylformulering som inneholder en essensiell olje

Info

Publication number
NO20080219L
NO20080219L NO20080219A NO20080219A NO20080219L NO 20080219 L NO20080219 L NO 20080219L NO 20080219 A NO20080219 A NO 20080219A NO 20080219 A NO20080219 A NO 20080219A NO 20080219 L NO20080219 L NO 20080219L
Authority
NO
Norway
Prior art keywords
essential oil
formulation containing
fentanyl formulation
fentanyl
formulations
Prior art date
Application number
NO20080219A
Other languages
English (en)
Norwegian (no)
Inventor
Clive Booles
Calvin Ross
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of NO20080219L publication Critical patent/NO20080219L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4468Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
NO20080219A 2005-07-08 2008-01-14 Fentanylformulering som inneholder en essensiell olje NO20080219L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0514043.9A GB0514043D0 (en) 2005-07-08 2005-07-08 Fentanyl formulation
PCT/GB2006/002526 WO2007007059A1 (en) 2005-07-08 2006-07-07 Fentanyl formulation containing an essential oil

Publications (1)

Publication Number Publication Date
NO20080219L true NO20080219L (no) 2008-02-05

Family

ID=34896944

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080219A NO20080219L (no) 2005-07-08 2008-01-14 Fentanylformulering som inneholder en essensiell olje

Country Status (15)

Country Link
EP (1) EP1904032B1 (pt)
JP (1) JP2009500387A (pt)
KR (1) KR20080044232A (pt)
CN (1) CN101247788A (pt)
AT (1) ATE490762T1 (pt)
AU (1) AU2006268052A1 (pt)
BR (1) BRPI0612771A2 (pt)
CA (1) CA2614420A1 (pt)
DE (1) DE602006018738D1 (pt)
GB (1) GB0514043D0 (pt)
IL (1) IL188639A0 (pt)
MX (1) MX2008000342A (pt)
NO (1) NO20080219L (pt)
WO (1) WO2007007059A1 (pt)
ZA (1) ZA200800147B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA006384B1 (ru) 2000-07-31 2005-12-29 Нюкомед Данмарк А/С Композиция фентанила для интраназального введения
ES2535233T3 (es) 2006-01-25 2015-05-06 Insys Therapeutics, Inc. Pulverización de fentanilo sublingual
DK2054031T3 (en) 2006-07-21 2016-05-17 Biodelivery Sciences Int Inc Transmucosal delivery devices with improved uptake
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
PT2180844T (pt) 2007-08-02 2018-04-06 Insys Dev Co Inc Nebulizador sub-lingual de fentanilo
GB2476494A (en) * 2009-12-24 2011-06-29 Norwich Pharma Technologies Ltd Formulation for the sublingual delivery of sufentanil
GB2481619B (en) * 2010-06-30 2012-06-20 Londonpharma Ltd Formulations and delivery devices for the sublingual administration of opioids
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
GB2487007B (en) * 2012-03-19 2013-06-05 Londonpharma Ltd COC containers and delivery devices for the sublingual administration of opioids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2017916C (en) * 1989-06-07 1999-02-02 Minoru Aoki Etoposide preparations
JP2002037735A (ja) * 2000-05-15 2002-02-06 Rohto Pharmaceut Co Ltd カフェイン類の安定化方法および粘膜適用組成物
WO2001097780A2 (en) * 2000-06-22 2001-12-27 Pharmasol Ltd Pharmaceutical compositions comprising an opioid analgesic
JP2003171311A (ja) * 2001-09-26 2003-06-20 Lion Corp 内服液剤組成物、それを含む内服液剤品
JP2006519770A (ja) * 2003-03-11 2006-08-31 アラキス リミテッド 新規組成物

Also Published As

Publication number Publication date
WO2007007059A1 (en) 2007-01-18
EP1904032A1 (en) 2008-04-02
GB0514043D0 (en) 2005-08-17
MX2008000342A (es) 2008-04-02
JP2009500387A (ja) 2009-01-08
ATE490762T1 (de) 2010-12-15
EP1904032B1 (en) 2010-12-08
DE602006018738D1 (de) 2011-01-20
AU2006268052A1 (en) 2007-01-18
CN101247788A (zh) 2008-08-20
ZA200800147B (en) 2009-07-29
KR20080044232A (ko) 2008-05-20
CA2614420A1 (en) 2007-01-18
IL188639A0 (en) 2008-04-13
BRPI0612771A2 (pt) 2010-11-30

Similar Documents

Publication Publication Date Title
NO20080219L (no) Fentanylformulering som inneholder en essensiell olje
CY1112722T1 (el) Μυκητοκτονες συνθεσεις
AR095848A2 (es) Derivados imidazolicos de propionamida moduladores de receptores opioides
NO20081160L (no) Benzimidazoltiofen forbindelser
AR050509A1 (es) Dispositivo de higiene oral
EA200802008A1 (ru) Фармацевтические композиции
MX2009003934A (es) Dosificador de dosis unitarias de detergente con componente que suministra fragancia.
NO20053775D0 (no) Diazepinoindol derivater som kinaseinhibitorer.
DK1594944T3 (da) Rengöringssammensætninger i tabletform
PA8792401A1 (es) Fenilendiaminas
NO20072071L (no) Flytende modulkonstruksjon
UY30451A1 (es) 18-metil-19-nor-androst-4-en-17,17-espiroéteres (18-metil-19-nor-20-espirox-4-en-3-onas),ase como preparaciones farmacéuticas que lo contienen.
UA100850C2 (ru) Средство для борьбы с паразитами на животных
ATE537822T1 (de) Antidepressivum
SV2006002001A (es) Inhibidores de quinasa ref. x - 16437
DK1740583T3 (da) Oxadiazolon-derivater som ppar-delta-agonister
AR051385A1 (es) Agentes de curtido a base de isocianato
CL2012002543A1 (es) Composicion endoparasiticida que comprende una combinacion de un compuesto de formula (i) derivado de amidoacetonitrilo y abamectina; y su uso para el control de endoparasitos, en particular helmintos.
EA200501698A1 (ru) Противовспенивающие композиции
WO2006069159A3 (en) Pharmaceutical compositions comprising amorphous benzimidazole compounds
WO2008146883A1 (ja) 睡眠改善剤
DK1749001T3 (da) 3-piperidinylisochroman-5-ol som dopaminagonister
WO2004080382A3 (en) Novel compositions containing fentanyl
HN2010001608A (es) Asociacion de un inhibidor de corriente sinusal if y de un beta-bloqueante
EA200870236A1 (ru) Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application